IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S: Financial statements 2014
CVR: 16584037
Source: annual report 2014, Danish Business Authority
01/04/2013 – 31/03/2014
IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S (CVR 16584037) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 13,378,185 and a net result of DKK 9,192,971 compared with DKK 7,119,974 the year before. That is an increase of 13.9% compared with the year before. Equity in the 2014 report amounted to DKK 78,722,380. The solvency ratio was 90.5%.
- Gross Profit
- DKK 13,378,185
- Profit/Loss
- DKK 9,192,971
- Equity
- DKK 78,722,380
- Total Assets
- DKK 86,944,633
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 13.4M | 9.2M | 78.7M | - |
| 2013 | - | 11.7M | 7.1M | 69.5M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of October 10, 2014, EY Godkendt Revisionspartnerselskab has been appointed auditor of IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S.
As of October 10, 2014, JUT NR. 2180 A/S has stepped down as auditor of IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S.
About IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S
IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S was a Danish company of the type Aktieselskab based in København S, founded in 1992. The company has been dissolved on 11 October 2019. The company was registered under the industry Engroshandel med kemiske produkter. The company was previously named NORDIC BIOSCIENCE DIAGNOSTICS A/S and OSTEOMETER BIOTECH A/S. The company has 1 employee (2018). In 2019, the company reported a gross profit of DKK 877,018 and a net result of DKK 1,209,814 compared with DKK 5,073,540 the year before. Equity in the 2019 report amounted to DKK 102,384,800.